The predictive and prognostic value of weight loss and body composition prior to and during immune checkpoint inhibition in recurrent or metastatic head and neck cancer patients

Abstract Background Response rates of immune checkpoint inhibitor (ICI) therapy for recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) are low. Patients and Methods This retrospective multicentre cohort study evaluates the predictive and prognostic value of weight loss and...

Full description

Bibliographic Details
Main Authors: Anna C. H. Willemsen, Nina De Moor, Jeroen Van Dessel, Laura W. J. Baijens, Michel Bila, Esther Hauben, Mari F. C. M. van denHout, Vincent Vander Poorten, Ann Hoeben, Paul M. Clement, Annemie M. W. J. Schols
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.5522